Page 2 - Caris Molecular News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Caris Life Sciences Accurately Identifies 21 Cancer Types Using Artificial Intelligence Derived Molecular Signatures
New Data Published in Translational Oncology
News provided by
Share this article
Share this article
IRVING, Texas, Jan. 19, 2021 /PRNewswire/  Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, today announced positive results from a study using MI GPSai™ (Genomic Prevalence Score) an artificial intelligence driven product using DNA sequencing and whole transcriptome data to aid in the diagnosis of cancer.
Caris MI GPSai algorithm trained on genomic data from over 34,000 cases and genomic and transcriptomic data from more than 23,000 cases and was validated on over 19,500 cases. MI GPSai predicted the tumor type in the labeled data set with an accuracy of over 94% on 93% of cases while deliberating amongst 21 possible categories of cancer. ....

New York , United States , Elisabeth Heath , John Marshall , Lindsey Bailys , David Spetzler , Jim Abraham , Matthew Oberley , Caris Pharmatech , Time Clinical Trial Solutions , Division Hematology , Elsevier Oncology Journal Network , Translational Sciences , Georgetown University , Oncology Network , Caris Life Sciences , Karmanos Cancer Institute , Department Of Medicine , Caris Life Sciences Media Company Contact , Genomic Prevalence Score , Unknown Primary , Translational Oncology , Oncology Journal , Associate Center Director , Karmanos Cancer , Executive Medical Director ,